News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dorval Allison
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Dorval Allison (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 10,000 shares
@ $3.45, valued at
$34.5k
Granted 27,000 shares
@ $0 |
|
| 06/08/2023 |
4
| Dorval Allison (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Dorval Allison (CFO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $30.94, valued at
$1.9M
|
|
| 11/30/2021 |
4
| Dorval Allison (CFO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $33.25, valued at
$4.5M
Granted 7,500 restricted stock units
@ $0 |
|
| 11/30/2021 |
3
| Dorval Allison (CFO) has filed a Form 3 on Verve Therapeutics, Inc. |
| 07/19/2021 |
4
| Dorval Allison (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $14.82, valued at
$370.5k
|
|
| 07/19/2021 |
3
| Dorval Allison (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 07/16/2021 |
4
| Dorval Allison (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 108,721 options to buy
@ $8.19, valued at
$890.4k
|
|
| 07/16/2021 |
3
| Dorval Allison (Director) has filed a Form 3 on PUMA BIOTECHNOLOGY, INC. |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2020 |
4
| Dorval Allison (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 3,128 shares
@ $13.36, valued at
$41.8k
|
|
| 01/17/2019 |
4
| Dorval Allison (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 50,000 options to buy
@ $9.1, valued at
$455k
|
|
| 11/09/2018 |
4
| Dorval Allison (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $13.99, valued at
$629.6k
|
|
| 06/15/2018 |
3
| Dorval Allison (Vice President, Finance) has filed a Form 3 on Voyager Therapeutics, Inc. |
|
|